Industry Research Reports

Home > Reports > Chemical & Material > Global Biological API Drug Manufacturing Market Research Report 2025

Global Biological API Drug Manufacturing Market Research Report 2025

Industry: Chemical & Material

Published Date: 2025-02-21

Pages: 100 Pages

Report ld: 4157750

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Biological API Drug Manufacturing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

It is an API produced by human, animal, microbial, genetic engineering or changing its source and through fermentation, bacterial culture, biotechnology and subsequent purification processes.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

MARKET SEGMENTATION

By Company

Lonza
Boehringer Ingelheim BioXcellence
Celltrion
DSM
Samsung BioLogics
Fujifilm Diosynth Biotechnologies
Cytovance Biologics
AbbVie
Baxter
CEPiA Sanofi
GSK
Pfizer CentreOne
Sandoz
Vetter
Wuxi Biologics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

In-House manufacturing
Contract manufacturing

Segment by Application

Monoclonal Antibody (mAb) Therapies
Vaccines
Insulin Therapies
Interferon Therapies
Other

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Biological API Drug Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological API Drug Manufacturing.

The Biological API Drug Manufacturing market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biological API Drug Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biological API Drug Manufacturing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Biological API Drug Manufacturing manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of Biological API Drug Manufacturing by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of Biological API Drug Manufacturing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Biological API Drug Manufacturing Market Overview

1.1 Product Definition

1.2 Biological API Drug Manufacturing by Type

1.2.1 Global Biological API Drug Manufacturing Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 In-House manufacturing

1.2.3 Contract manufacturing

1.3 Biological API Drug Manufacturing by Application

1.3.1 Global Biological API Drug Manufacturing Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Monoclonal Antibody (mAb) Therapies

1.3.3 Vaccines

1.3.4 Insulin Therapies

1.3.5 Interferon Therapies

1.3.6 Other

1.4 Global Market Growth Prospects

1.4.1 Global Biological API Drug Manufacturing Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global Biological API Drug Manufacturing Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global Biological API Drug Manufacturing Production Estimates and Forecasts (2020-2031)

1.4.4 Global Biological API Drug Manufacturing Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Biological API Drug Manufacturing Production Market Share by Manufacturers (2020-2025)

2.2 Global Biological API Drug Manufacturing Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Biological API Drug Manufacturing, Industry Ranking, 2023 VS 2024

2.4 Global Biological API Drug Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Biological API Drug Manufacturing Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Biological API Drug Manufacturing, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Biological API Drug Manufacturing, Product Offered and Application

2.8 Global Key Manufacturers of Biological API Drug Manufacturing, Date of Enter into This Industry

2.9 Biological API Drug Manufacturing Market Competitive Situation and Trends

2.9.1 Biological API Drug Manufacturing Market Concentration Rate

2.9.2 Global 5 and 10 Largest Biological API Drug Manufacturing Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Biological API Drug Manufacturing Production by Region

3.1 Global Biological API Drug Manufacturing Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Biological API Drug Manufacturing Production Value by Region (2020-2031)

3.2.1 Global Biological API Drug Manufacturing Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Biological API Drug Manufacturing by Region (2026-2031)

3.3 Global Biological API Drug Manufacturing Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Biological API Drug Manufacturing Production Volume by Region (2020-2031)

3.4.1 Global Biological API Drug Manufacturing Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Biological API Drug Manufacturing by Region (2026-2031)

3.5 Global Biological API Drug Manufacturing Market Price Analysis by Region (2020-2025)

3.6 Global Biological API Drug Manufacturing Production and Value, Year-over-Year Growth

3.6.1 North America Biological API Drug Manufacturing Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Biological API Drug Manufacturing Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Biological API Drug Manufacturing Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan Biological API Drug Manufacturing Production Value Estimates and Forecasts (2020-2031)

4 Biological API Drug Manufacturing Consumption by Region

4.1 Global Biological API Drug Manufacturing Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Biological API Drug Manufacturing Consumption by Region (2020-2031)

4.2.1 Global Biological API Drug Manufacturing Consumption by Region (2020-2025)

4.2.2 Global Biological API Drug Manufacturing Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Biological API Drug Manufacturing Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Biological API Drug Manufacturing Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Biological API Drug Manufacturing Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Biological API Drug Manufacturing Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Biological API Drug Manufacturing Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Biological API Drug Manufacturing Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Biological API Drug Manufacturing Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Biological API Drug Manufacturing Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Biological API Drug Manufacturing Production by Type (2020-2031)

5.1.1 Global Biological API Drug Manufacturing Production by Type (2020-2025)

5.1.2 Global Biological API Drug Manufacturing Production by Type (2026-2031)

5.1.3 Global Biological API Drug Manufacturing Production Market Share by Type (2020-2031)

5.2 Global Biological API Drug Manufacturing Production Value by Type (2020-2031)

5.2.1 Global Biological API Drug Manufacturing Production Value by Type (2020-2025)

5.2.2 Global Biological API Drug Manufacturing Production Value by Type (2026-2031)

5.2.3 Global Biological API Drug Manufacturing Production Value Market Share by Type (2020-2031)

5.3 Global Biological API Drug Manufacturing Price by Type (2020-2031)

6 Segment by Application

6.1 Global Biological API Drug Manufacturing Production by Application (2020-2031)

6.1.1 Global Biological API Drug Manufacturing Production by Application (2020-2025)

6.1.2 Global Biological API Drug Manufacturing Production by Application (2026-2031)

6.1.3 Global Biological API Drug Manufacturing Production Market Share by Application (2020-2031)

6.2 Global Biological API Drug Manufacturing Production Value by Application (2020-2031)

6.2.1 Global Biological API Drug Manufacturing Production Value by Application (2020-2025)

6.2.2 Global Biological API Drug Manufacturing Production Value by Application (2026-2031)

6.2.3 Global Biological API Drug Manufacturing Production Value Market Share by Application (2020-2031)

6.3 Global Biological API Drug Manufacturing Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Lonza

7.1.1 Lonza Biological API Drug Manufacturing Company Information

7.1.2 Lonza Biological API Drug Manufacturing Product Portfolio

7.1.3 Lonza Biological API Drug Manufacturing Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Lonza Main Business and Markets Served

7.1.5 Lonza Recent Developments/Updates

7.2 Boehringer Ingelheim BioXcellence

7.2.1 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Company Information

7.2.2 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Product Portfolio

7.2.3 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Boehringer Ingelheim BioXcellence Main Business and Markets Served

7.2.5 Boehringer Ingelheim BioXcellence Recent Developments/Updates

7.3 Celltrion

7.3.1 Celltrion Biological API Drug Manufacturing Company Information

7.3.2 Celltrion Biological API Drug Manufacturing Product Portfolio

7.3.3 Celltrion Biological API Drug Manufacturing Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Celltrion Main Business and Markets Served

7.3.5 Celltrion Recent Developments/Updates

7.4 DSM

7.4.1 DSM Biological API Drug Manufacturing Company Information

7.4.2 DSM Biological API Drug Manufacturing Product Portfolio

7.4.3 DSM Biological API Drug Manufacturing Production, Value, Price and Gross Margin (2020-2025)

7.4.4 DSM Main Business and Markets Served

7.4.5 DSM Recent Developments/Updates

7.5 Samsung BioLogics

7.5.1 Samsung BioLogics Biological API Drug Manufacturing Company Information

7.5.2 Samsung BioLogics Biological API Drug Manufacturing Product Portfolio

7.5.3 Samsung BioLogics Biological API Drug Manufacturing Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Samsung BioLogics Main Business and Markets Served

7.5.5 Samsung BioLogics Recent Developments/Updates

7.6 Fujifilm Diosynth Biotechnologies

7.6.1 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Company Information

7.6.2 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Product Portfolio

7.6.3 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Fujifilm Diosynth Biotechnologies Main Business and Markets Served

7.6.5 Fujifilm Diosynth Biotechnologies Recent Developments/Updates

7.7 Cytovance Biologics

7.7.1 Cytovance Biologics Biological API Drug Manufacturing Company Information

7.7.2 Cytovance Biologics Biological API Drug Manufacturing Product Portfolio

7.7.3 Cytovance Biologics Biological API Drug Manufacturing Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Cytovance Biologics Main Business and Markets Served

7.7.5 Cytovance Biologics Recent Developments/Updates

7.8 AbbVie

7.8.1 AbbVie Biological API Drug Manufacturing Company Information

7.8.2 AbbVie Biological API Drug Manufacturing Product Portfolio

7.8.3 AbbVie Biological API Drug Manufacturing Production, Value, Price and Gross Margin (2020-2025)

7.8.4 AbbVie Main Business and Markets Served

7.8.5 AbbVie Recent Developments/Updates

7.9 Baxter

7.9.1 Baxter Biological API Drug Manufacturing Company Information

7.9.2 Baxter Biological API Drug Manufacturing Product Portfolio

7.9.3 Baxter Biological API Drug Manufacturing Production, Value, Price and Gross Margin (2020-2025)

7.9.4 Baxter Main Business and Markets Served

7.9.5 Baxter Recent Developments/Updates

7.10 CEPiA Sanofi

7.10.1 CEPiA Sanofi Biological API Drug Manufacturing Company Information

7.10.2 CEPiA Sanofi Biological API Drug Manufacturing Product Portfolio

7.10.3 CEPiA Sanofi Biological API Drug Manufacturing Production, Value, Price and Gross Margin (2020-2025)

7.10.4 CEPiA Sanofi Main Business and Markets Served

7.10.5 CEPiA Sanofi Recent Developments/Updates

7.11 GSK

7.11.1 GSK Biological API Drug Manufacturing Company Information

7.11.2 GSK Biological API Drug Manufacturing Product Portfolio

7.11.3 GSK Biological API Drug Manufacturing Production, Value, Price and Gross Margin (2020-2025)

7.11.4 GSK Main Business and Markets Served

7.11.5 GSK Recent Developments/Updates

7.12 Pfizer CentreOne

7.12.1 Pfizer CentreOne Biological API Drug Manufacturing Company Information

7.12.2 Pfizer CentreOne Biological API Drug Manufacturing Product Portfolio

7.12.3 Pfizer CentreOne Biological API Drug Manufacturing Production, Value, Price and Gross Margin (2020-2025)

7.12.4 Pfizer CentreOne Main Business and Markets Served

7.12.5 Pfizer CentreOne Recent Developments/Updates

7.13 Sandoz

7.13.1 Sandoz Biological API Drug Manufacturing Company Information

7.13.2 Sandoz Biological API Drug Manufacturing Product Portfolio

7.13.3 Sandoz Biological API Drug Manufacturing Production, Value, Price and Gross Margin (2020-2025)

7.13.4 Sandoz Main Business and Markets Served

7.13.5 Sandoz Recent Developments/Updates

7.14 Vetter

7.14.1 Vetter Biological API Drug Manufacturing Company Information

7.14.2 Vetter Biological API Drug Manufacturing Product Portfolio

7.14.3 Vetter Biological API Drug Manufacturing Production, Value, Price and Gross Margin (2020-2025)

7.14.4 Vetter Main Business and Markets Served

7.14.5 Vetter Recent Developments/Updates

7.15 Wuxi Biologics

7.15.1 Wuxi Biologics Biological API Drug Manufacturing Company Information

7.15.2 Wuxi Biologics Biological API Drug Manufacturing Product Portfolio

7.15.3 Wuxi Biologics Biological API Drug Manufacturing Production, Value, Price and Gross Margin (2020-2025)

7.15.4 Wuxi Biologics Main Business and Markets Served

7.15.5 Wuxi Biologics Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Biological API Drug Manufacturing Industry Chain Analysis

8.2 Biological API Drug Manufacturing Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Biological API Drug Manufacturing Production Mode & Process Analysis

8.4 Biological API Drug Manufacturing Sales and Marketing

8.4.1 Biological API Drug Manufacturing Sales Channels

8.4.2 Biological API Drug Manufacturing Distributors

8.5 Biological API Drug Manufacturing Customer Analysis

9 Biological API Drug Manufacturing Market Dynamics

9.1 Biological API Drug Manufacturing Industry Trends

9.2 Biological API Drug Manufacturing Market Drivers

9.3 Biological API Drug Manufacturing Market Challenges

9.4 Biological API Drug Manufacturing Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Biological API Drug Manufacturing Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Biological API Drug Manufacturing Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Biological API Drug Manufacturing Production Capacity (K MT) by Manufacturers in 2024

Table 4. Global Biological API Drug Manufacturing Production by Manufacturers (2020-2025) & (K MT)

Table 5. Global Biological API Drug Manufacturing Production Market Share by Manufacturers (2020-2025)

Table 6. Global Biological API Drug Manufacturing Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Biological API Drug Manufacturing Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Biological API Drug Manufacturing, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Biological API Drug Manufacturing as of 2024)

Table 10. Global Market Biological API Drug Manufacturing Average Price by Manufacturers (USD/MT) & (2020-2025)

Table 11. Global Key Manufacturers of Biological API Drug Manufacturing, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Biological API Drug Manufacturing, Product Offered and Application

Table 13. Global Key Manufacturers of Biological API Drug Manufacturing, Date of Enter into This Industry

Table 14. Global Biological API Drug Manufacturing Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Biological API Drug Manufacturing Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Biological API Drug Manufacturing Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Biological API Drug Manufacturing Production Value Market Share by Region (2020-2025)

Table 19. Global Biological API Drug Manufacturing Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Biological API Drug Manufacturing Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Biological API Drug Manufacturing Production Comparison by Region: 2020 VS 2024 VS 2031 (K MT)

Table 22. Global Biological API Drug Manufacturing Production (K MT) by Region (2020-2025)

Table 23. Global Biological API Drug Manufacturing Production Market Share by Region (2020-2025)

Table 24. Global Biological API Drug Manufacturing Production (K MT) Forecast by Region (2026-2031)

Table 25. Global Biological API Drug Manufacturing Production Market Share Forecast by Region (2026-2031)

Table 26. Global Biological API Drug Manufacturing Market Average Price (USD/MT) by Region (2020-2025)

Table 27. Global Biological API Drug Manufacturing Market Average Price (USD/MT) by Region (2026-2031)

Table 28. Global Biological API Drug Manufacturing Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K MT)

Table 29. Global Biological API Drug Manufacturing Consumption by Region (2020-2025) & (K MT)

Table 30. Global Biological API Drug Manufacturing Consumption Market Share by Region (2020-2025)

Table 31. Global Biological API Drug Manufacturing Forecasted Consumption by Region (2026-2031) & (K MT)

Table 32. Global Biological API Drug Manufacturing Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Biological API Drug Manufacturing Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K MT)

Table 34. North America Biological API Drug Manufacturing Consumption by Country (2020-2025) & (K MT)

Table 35. North America Biological API Drug Manufacturing Consumption by Country (2026-2031) & (K MT)

Table 36. Europe Biological API Drug Manufacturing Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K MT)

Table 37. Europe Biological API Drug Manufacturing Consumption by Country (2020-2025) & (K MT)

Table 38. Europe Biological API Drug Manufacturing Consumption by Country (2026-2031) & (K MT)

Table 39. Asia Pacific Biological API Drug Manufacturing Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K MT)

Table 40. Asia Pacific Biological API Drug Manufacturing Consumption by Region (2020-2025) & (K MT)

Table 41. Asia Pacific Biological API Drug Manufacturing Consumption by Region (2026-2031) & (K MT)

Table 42. Latin America, Middle East & Africa Biological API Drug Manufacturing Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K MT)

Table 43. Latin America, Middle East & Africa Biological API Drug Manufacturing Consumption by Country (2020-2025) & (K MT)

Table 44. Latin America, Middle East & Africa Biological API Drug Manufacturing Consumption by Country (2026-2031) & (K MT)

Table 45. Global Biological API Drug Manufacturing Production (K MT) by Type (2020-2025)

Table 46. Global Biological API Drug Manufacturing Production (K MT) by Type (2026-2031)

Table 47. Global Biological API Drug Manufacturing Production Market Share by Type (2020-2025)

Table 48. Global Biological API Drug Manufacturing Production Market Share by Type (2026-2031)

Table 49. Global Biological API Drug Manufacturing Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Biological API Drug Manufacturing Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Biological API Drug Manufacturing Production Value Market Share by Type (2020-2025)

Table 52. Global Biological API Drug Manufacturing Production Value Market Share by Type (2026-2031)

Table 53. Global Biological API Drug Manufacturing Price (USD/MT) by Type (2020-2025)

Table 54. Global Biological API Drug Manufacturing Price (USD/MT) by Type (2026-2031)

Table 55. Global Biological API Drug Manufacturing Production (K MT) by Application (2020-2025)

Table 56. Global Biological API Drug Manufacturing Production (K MT) by Application (2026-2031)

Table 57. Global Biological API Drug Manufacturing Production Market Share by Application (2020-2025)

Table 58. Global Biological API Drug Manufacturing Production Market Share by Application (2026-2031)

Table 59. Global Biological API Drug Manufacturing Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Biological API Drug Manufacturing Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Biological API Drug Manufacturing Production Value Market Share by Application (2020-2025)

Table 62. Global Biological API Drug Manufacturing Production Value Market Share by Application (2026-2031)

Table 63. Global Biological API Drug Manufacturing Price (USD/MT) by Application (2020-2025)

Table 64. Global Biological API Drug Manufacturing Price (USD/MT) by Application (2026-2031)

Table 65. Lonza Biological API Drug Manufacturing Company Information

Table 66. Lonza Biological API Drug Manufacturing Specification and Application

Table 67. Lonza Biological API Drug Manufacturing Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 68. Lonza Main Business and Markets Served

Table 69. Lonza Recent Developments/Updates

Table 70. Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Company Information

Table 71. Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Specification and Application

Table 72. Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 73. Boehringer Ingelheim BioXcellence Main Business and Markets Served

Table 74. Boehringer Ingelheim BioXcellence Recent Developments/Updates

Table 75. Celltrion Biological API Drug Manufacturing Company Information

Table 76. Celltrion Biological API Drug Manufacturing Specification and Application

Table 77. Celltrion Biological API Drug Manufacturing Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 78. Celltrion Main Business and Markets Served

Table 79. Celltrion Recent Developments/Updates

Table 80. DSM Biological API Drug Manufacturing Company Information

Table 81. DSM Biological API Drug Manufacturing Specification and Application

Table 82. DSM Biological API Drug Manufacturing Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 83. DSM Main Business and Markets Served

Table 84. DSM Recent Developments/Updates

Table 85. Samsung BioLogics Biological API Drug Manufacturing Company Information

Table 86. Samsung BioLogics Biological API Drug Manufacturing Specification and Application

Table 87. Samsung BioLogics Biological API Drug Manufacturing Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 88. Samsung BioLogics Main Business and Markets Served

Table 89. Samsung BioLogics Recent Developments/Updates

Table 90. Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Company Information

Table 91. Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Specification and Application

Table 92. Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 93. Fujifilm Diosynth Biotechnologies Main Business and Markets Served

Table 94. Fujifilm Diosynth Biotechnologies Recent Developments/Updates

Table 95. Cytovance Biologics Biological API Drug Manufacturing Company Information

Table 96. Cytovance Biologics Biological API Drug Manufacturing Specification and Application

Table 97. Cytovance Biologics Biological API Drug Manufacturing Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 98. Cytovance Biologics Main Business and Markets Served

Table 99. Cytovance Biologics Recent Developments/Updates

Table 100. AbbVie Biological API Drug Manufacturing Company Information

Table 101. AbbVie Biological API Drug Manufacturing Specification and Application

Table 102. AbbVie Biological API Drug Manufacturing Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 103. AbbVie Main Business and Markets Served

Table 104. AbbVie Recent Developments/Updates

Table 105. Baxter Biological API Drug Manufacturing Company Information

Table 106. Baxter Biological API Drug Manufacturing Specification and Application

Table 107. Baxter Biological API Drug Manufacturing Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 108. Baxter Main Business and Markets Served

Table 109. Baxter Recent Developments/Updates

Table 110. CEPiA Sanofi Biological API Drug Manufacturing Company Information

Table 111. CEPiA Sanofi Biological API Drug Manufacturing Specification and Application

Table 112. CEPiA Sanofi Biological API Drug Manufacturing Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 113. CEPiA Sanofi Main Business and Markets Served

Table 114. CEPiA Sanofi Recent Developments/Updates

Table 115. GSK Biological API Drug Manufacturing Company Information

Table 116. GSK Biological API Drug Manufacturing Specification and Application

Table 117. GSK Biological API Drug Manufacturing Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 118. GSK Main Business and Markets Served

Table 119. GSK Recent Developments/Updates

Table 120. Pfizer CentreOne Biological API Drug Manufacturing Company Information

Table 121. Pfizer CentreOne Biological API Drug Manufacturing Specification and Application

Table 122. Pfizer CentreOne Biological API Drug Manufacturing Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 123. Pfizer CentreOne Main Business and Markets Served

Table 124. Pfizer CentreOne Recent Developments/Updates

Table 125. Sandoz Biological API Drug Manufacturing Company Information

Table 126. Sandoz Biological API Drug Manufacturing Specification and Application

Table 127. Sandoz Biological API Drug Manufacturing Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 128. Sandoz Main Business and Markets Served

Table 129. Sandoz Recent Developments/Updates

Table 130. Vetter Biological API Drug Manufacturing Company Information

Table 131. Vetter Biological API Drug Manufacturing Specification and Application

Table 132. Vetter Biological API Drug Manufacturing Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 133. Vetter Main Business and Markets Served

Table 134. Vetter Recent Developments/Updates

Table 135. Wuxi Biologics Biological API Drug Manufacturing Company Information

Table 136. Wuxi Biologics Biological API Drug Manufacturing Specification and Application

Table 137. Wuxi Biologics Biological API Drug Manufacturing Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 138. Wuxi Biologics Main Business and Markets Served

Table 139. Wuxi Biologics Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Biological API Drug Manufacturing Distributors List

Table 143. Biological API Drug Manufacturing Customers List

Table 144. Biological API Drug Manufacturing Market Trends

Table 145. Biological API Drug Manufacturing Market Drivers

Table 146. Biological API Drug Manufacturing Market Challenges

Table 147. Biological API Drug Manufacturing Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Biological API Drug Manufacturing

Figure 2. Global Biological API Drug Manufacturing Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Biological API Drug Manufacturing Market Share by Type: 2024 VS 2031

Figure 4. In-House manufacturing Product Picture

Figure 5. Contract manufacturing Product Picture

Figure 6. Global Biological API Drug Manufacturing Market Value by Application, (US$ Million) & (2020-2031)

Figure 7. Global Biological API Drug Manufacturing Market Share by Application: 2024 VS 2031

Figure 8. Monoclonal Antibody (mAb) Therapies

Figure 9. Vaccines

Figure 10. Insulin Therapies

Figure 11. Interferon Therapies

Figure 12. Other

Figure 13. Global Biological API Drug Manufacturing Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Biological API Drug Manufacturing Production Value (US$ Million) & (2020-2031)

Figure 15. Global Biological API Drug Manufacturing Production Capacity (K MT) & (2020-2031)

Figure 16. Global Biological API Drug Manufacturing Production (K MT) & (2020-2031)

Figure 17. Global Biological API Drug Manufacturing Average Price (USD/MT) & (2020-2031)

Figure 18. Biological API Drug Manufacturing Report Years Considered

Figure 19. Biological API Drug Manufacturing Production Share by Manufacturers in 2024

Figure 20. Global Biological API Drug Manufacturing Production Value Share by Manufacturers (2024)

Figure 21. Biological API Drug Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. The Global 5 and 10 Largest Players: Market Share by Biological API Drug Manufacturing Revenue in 2024

Figure 23. Global Biological API Drug Manufacturing Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 24. Global Biological API Drug Manufacturing Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 25. Global Biological API Drug Manufacturing Production Comparison by Region: 2020 VS 2024 VS 2031 (K MT)

Figure 26. Global Biological API Drug Manufacturing Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 27. North America Biological API Drug Manufacturing Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. Europe Biological API Drug Manufacturing Production Value (US$ Million) Growth Rate (2020-2031)

Figure 29. China Biological API Drug Manufacturing Production Value (US$ Million) Growth Rate (2020-2031)

Figure 30. Japan Biological API Drug Manufacturing Production Value (US$ Million) Growth Rate (2020-2031)

Figure 31. Global Biological API Drug Manufacturing Consumption by Region: 2020 VS 2024 VS 2031 (K MT)

Figure 32. Global Biological API Drug Manufacturing Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 33. North America Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 34. North America Biological API Drug Manufacturing Consumption Market Share by Country (2020-2031)

Figure 35. U.S. Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 36. Canada Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 37. Europe Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 38. Europe Biological API Drug Manufacturing Consumption Market Share by Country (2020-2031)

Figure 39. Germany Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 40. France Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 41. U.K. Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 42. Italy Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 43. Russia Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 44. Asia Pacific Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 45. Asia Pacific Biological API Drug Manufacturing Consumption Market Share by Region (2020-2031)

Figure 46. China Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 47. Japan Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 48. South Korea Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 49. China Taiwan Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 50. Southeast Asia Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 51. India Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 52. Latin America, Middle East & Africa Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 53. Latin America, Middle East & Africa Biological API Drug Manufacturing Consumption Market Share by Country (2020-2031)

Figure 54. Mexico Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 55. Brazil Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 56. Turkey Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 57. GCC Countries Biological API Drug Manufacturing Consumption and Growth Rate (2020-2031) & (K MT)

Figure 58. Global Production Market Share of Biological API Drug Manufacturing by Type (2020-2031)

Figure 59. Global Production Value Market Share of Biological API Drug Manufacturing by Type (2020-2031)

Figure 60. Global Biological API Drug Manufacturing Price (USD/MT) by Type (2020-2031)

Figure 61. Global Production Market Share of Biological API Drug Manufacturing by Application (2020-2031)

Figure 62. Global Production Value Market Share of Biological API Drug Manufacturing by Application (2020-2031)

Figure 63. Global Biological API Drug Manufacturing Price (USD/MT) by Application (2020-2031)

Figure 64. Biological API Drug Manufacturing Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Biological API Drug Manufacturing market? zhanKai

The top companies in the global Biological API Drug Manufacturing market are Lonza、Boehringer Ingelheim BioXcellence、Celltrion.

Related Reports

Biological API Drug Manufacturing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biological API Drug Manufacturing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 139
USD 3950.00
(Single User License)
Global Biological API Drug Manufacturing Market Research Report 2026
The global Biological API Drug Manufacturing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-25
Pages: 145
USD 2900.00
(Single User License)
Global Biological API Drug Manufacturing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Biological API Drug Manufacturing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 167
USD 4900.00
(Single User License)
Global Biological API Drug Manufacturing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biological API Drug Manufacturing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 95
USD 4250.00
(Single User License)
Biological API Drug Manufacturing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biological API Drug Manufacturing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 129
USD 3950.00
(Single User License)
Global Biological API Drug Manufacturing Market Insights, Forecast to 2030
It is an API produced by human, animal, microbial, genetic engineering or changing its source and through fermentation, bacterial culture, biotechnology and subsequent purification processes.
Published Date: 2024-04-16
Pages: 113
USD 4900.00
(Single User License)
Biological API Drug Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
It is an API produced by human, animal, microbial, genetic engineering or changing its source and through fermentation, bacterial culture, biotechnology and subsequent purification processes.
Published Date: 2024-01-25
Pages: 131
USD 3950.00
(Single User License)
Global Biological API Drug Manufacturing Market Research Report 2024
It is an API produced by human, animal, microbial, genetic engineering or changing its source and through fermentation, bacterial culture, biotechnology and subsequent purification processes.
Published Date: 2024-01-11
Pages: 113
USD 2900.00
(Single User License)

Biological API Drug Manufacturing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biological API Drug Manufacturing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 139
USD 3950.00 (Single User License)
Global Biological API Drug Manufacturing Market Research Report 2026
The global Biological API Drug Manufacturing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-25
Pages: 145
USD 2900.00 (Single User License)
Global Biological API Drug Manufacturing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Biological API Drug Manufacturing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 167
USD 4900.00 (Single User License)
Global Biological API Drug Manufacturing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biological API Drug Manufacturing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 95
USD 4250.00 (Single User License)
Biological API Drug Manufacturing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biological API Drug Manufacturing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 129
USD 3950.00 (Single User License)
Global Biological API Drug Manufacturing Market Insights, Forecast to 2030
It is an API produced by human, animal, microbial, genetic engineering or changing its source and through fermentation, bacterial culture, biotechnology and subsequent purification processes.
Published: 2024-04-16
Pages: 113
USD 4900.00 (Single User License)
Biological API Drug Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
It is an API produced by human, animal, microbial, genetic engineering or changing its source and through fermentation, bacterial culture, biotechnology and subsequent purification processes.
Published: 2024-01-25
Pages: 131
USD 3950.00 (Single User License)
Global Biological API Drug Manufacturing Market Research Report 2024
It is an API produced by human, animal, microbial, genetic engineering or changing its source and through fermentation, bacterial culture, biotechnology and subsequent purification processes.
Published: 2024-01-11
Pages: 113
USD 2900.00 (Single User License)